Steve Duffy

Most Recent Articles by Steve Duffy

Opioid Dependence Prevention Treatments Compared

Opioid Dependence Prevention Treatments Compared

By

Significantly less heroin cravings were reported in the extended-release naltrexone group and treatment satisfaction was also reported higher in this group compared to the buprenorphine-naloxone group.

FDA Approves Cefaly for Acute Treatment of Migraine

FDA Approves Cefaly for Acute Treatment of Migraine

By

Cefaly Technology announced that the FDA has cleared for use the Cefaly Acute medical device for the treatment of migraines, with or without aura, in patients ≥18 years of age.

Emerging Dosing Device Tech Could Print Multiple, Custom-Dose Medications

Emerging Dosing Device Tech Could Print Multiple, Custom-Dose Medications

By

Researchers are working on a new technology that could potentially allow clinicians the ability to print multiple drugs onto a dissolvable strip, a microneedle patch, or another type of dosing device.

Illegal Online Drug Sale Crackdown by FDA, Interpol

Illegal Online Drug Sale Crackdown by FDA, Interpol

By

The Food and Drug Administration, in partnership with Interpol, has cracked down on over 500 websites that illegally sell potentially dangerous, unapproved medications to US consumers.

CVS to Limit Opioids Dispensed to Opioid-Naive Patients to a 7-day Supply

CVS to Limit Opioids Dispensed to Opioid-Naive Patients to a 7-day Supply

By

At the pharmacy level, a greater emphasis will be placed on counseling to help patients understand the risks associated with opioid use based on the new Centers for Disease Control and Prevention (CDC) guidelines.

More Articles by Steve Duffy

Sign Up for Free e-Newsletters